Consider New Antibiotics After Treatment Failure for MRSA Skin Infections
August 2014
You'll see several new antibiotics for treating gram-positive infections...tedizolid, dalbavancin, and oritavancin.
Tedizolid (Sivextro) and dalbavancin (Dalvance) are available now...and oritavancin (Orbactiv) is expected later this year.
This is progress in the "10 x '20 Initiative"... 10 new antibiotics available by 2020. Important targets are the "ESKAPE" bacteria...E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and Enterobacter species.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote